Harmony Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Harmony Biosciences Holdings
HRMY Stock  USD 34.78  0.46  1.34%   
Harmony Biosciences financial statements provide useful quarterly and yearly information to potential Harmony Biosciences Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Harmony Biosciences financial statements helps investors assess Harmony Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Harmony Biosciences' valuation are summarized below:
Gross Profit
557.9 M
Profit Margin
0.2036
Market Capitalization
2 B
Enterprise Value Revenue
2.3504
Revenue
714.7 M
We have found one hundred twenty available fundamental trends for Harmony Biosciences, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Harmony Biosciences regular market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Enterprise Value is likely to rise to about 2.4 B in 2025, whereas Market Cap is likely to drop slightly above 1.8 B in 2025.

Harmony Biosciences Total Revenue

750.47 Million

Check Harmony Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harmony Biosciences' main balance sheet or income statement drivers, such as Tax Provision of 48.6 M, Net Interest Income of 1.1 M or Depreciation And Amortization of 16.4 M, as well as many indicators such as Price To Sales Ratio of 2.6, Dividend Yield of 0.0 or PTB Ratio of 3.12. Harmony financial statements analysis is a perfect complement when working with Harmony Biosciences Valuation or Volatility modules.
  
Check out the analysis of Harmony Biosciences Correlation against competitors.

Harmony Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets556.4 M999.2 M300.7 M
Slightly volatile
Other Current Liabilities86.6 M145.1 M42.8 M
Slightly volatile
Total Current Liabilities99.5 M175.1 M49.4 M
Slightly volatile
Other Liabilities1.5 M1.8 M983.6 K
Slightly volatile
Property Plant And Equipment Net784.6 K1.3 M1.3 M
Slightly volatile
Accounts Payable7.3 M13.7 M4.1 M
Slightly volatile
Cash248.2 M453 M156 M
Slightly volatile
Non Current Assets Total227.1 M419.9 M105.8 M
Slightly volatile
Non Currrent Assets Other3.8 M6.2 M2.3 M
Slightly volatile
Other Assets105.3 M100.3 M24.7 M
Slightly volatile
Cash And Short Term Investments269.4 M467.2 M165.8 M
Slightly volatile
Common Stock Shares Outstanding64.2 M57.9 M54.2 M
Slightly volatile
Liabilities And Stockholders Equity556.4 M999.2 M300.7 M
Slightly volatile
Non Current Liabilities Total161.1 M165 M74.4 M
Slightly volatile
Other Current Assets12.6 M21.8 M7 M
Slightly volatile
Other Stockholder Equity615.8 M656.9 M445.5 M
Slightly volatile
Total Liabilities260.6 M340 M123.8 M
Slightly volatile
Property Plant And Equipment Gross1 M844.2 K1.3 M
Slightly volatile
Total Current Assets329.4 M579.3 M194.9 M
Slightly volatile
Capital Stock855900208.1 M
Slightly volatile
Non Current Liabilities Other1.7 M1.9 M929.7 K
Slightly volatile
Net Working Capital229.9 M404.2 M145.5 M
Slightly volatile
Common Stock800900981
Slightly volatile
Property Plant Equipment837.9 K515.7 K1.2 M
Slightly volatile
Short and Long Term Debt Total15.4 M16.2 M111.4 M
Very volatile
Long Term Debt185.8 M163 M130 M
Slightly volatile
Intangible Assets144.8 M113.3 M99 M
Slightly volatile
Common Stock Total Equity800900981
Slightly volatile
Long Term Debt Total153 M170.7 M189.4 M
Slightly volatile
Capital Surpluse696.9 M776.4 M618.9 M
Slightly volatile
Deferred Long Term Liabilities169.6 K190.8 K208 K
Slightly volatile
Current Deferred Revenue95 M141.7 M67.3 M
Slightly volatile
Short and Long Term Debt9.7 M16.2 M4.2 M
Slightly volatile
Short Term Debt9.7 M16.2 M4.2 M
Slightly volatile

Harmony Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization16.4 M24.1 M7.6 M
Slightly volatile
Selling General Administrative69.4 M110.4 M38.1 M
Slightly volatile
Selling And Marketing Expenses74.3 M110.9 M42.6 M
Slightly volatile
Other Operating Expenses280.6 M523.9 M149.9 M
Slightly volatile
Research Development153.1 M145.8 M42.3 M
Slightly volatile
Total Operating Expenses210.4 M367.1 M117.6 M
Slightly volatile
Reconciled Depreciation16.4 M24.1 M7.6 M
Slightly volatile
Preferred Stock And Other Adjustments21.5 M24.2 M26.4 M
Slightly volatile
Interest Income10.1 M18.5 M3.1 M
Slightly volatile

Harmony Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation44.7 M42.6 M11.6 M
Slightly volatile
Begin Period Cash Flow193.7 M311.9 M140.4 M
Slightly volatile
Depreciation16.4 M24.1 M7.6 M
Slightly volatile
Other Non Cash Items18.5 M36.9 M9.6 M
Slightly volatile
Capital Expenditures1.1 M1.2 M17.8 M
Pretty Stable
Change To Operating Activities11.1 M14.8 M5.8 M
Slightly volatile
End Period Cash Flow248.8 M453.3 M156.5 M
Slightly volatile
Dividends Paid4.3 M4.5 M103.9 M
Slightly volatile
Cash And Cash Equivalents Changes8.1 M8.5 M142.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.62.7387248
Slightly volatile
Days Sales Outstanding40.2842.4033179
Slightly volatile
Average Payables1.7 M2.2 M1.9 M
Slightly volatile
Stock Based Compensation To Revenue0.05660.05961.0525
Slightly volatile
Capex To Depreciation0.04540.04787.0372
Pretty Stable
EV To Sales2.022.1276256
Slightly volatile
Inventory Turnover11.3421.78596.8398
Slightly volatile
Days Of Inventory On Hand15.9216.7539167
Slightly volatile
Payables Turnover12.2211.40977.5133
Slightly volatile
Sales General And Administrative To Revenue0.150.15443.8656
Slightly volatile
Research And Ddevelopement To Revenue0.190.2047.3123
Slightly volatile
Capex To Revenue0.00150.001613.283
Slightly volatile
Cash Per Share8.628.21273.2487
Slightly volatile
Days Payables Outstanding30.3931.99031.7 K
Slightly volatile
Income Quality0.961.51091.0717
Pretty Stable
Intangibles To Total Assets0.110.11340.5068
Slightly volatile
Current Ratio5.023.30858.3046
Slightly volatile
Receivables Turnover5.588.60783.756
Slightly volatile
Graham Number14.7425.822910.0799
Slightly volatile
Capex Per Share0.01930.02030.2965
Pretty Stable
Revenue Per Share13.1912.56443.25
Slightly volatile
Interest Debt Per Share0.560.59324.8042
Slightly volatile
Debt To Assets0.01540.01632.1907
Slightly volatile
Short Term Coverage Ratios12.8513.527444.0361
Slightly volatile
Operating Cycle56.259.1572345
Slightly volatile
Days Of Payables Outstanding30.3931.99031.7 K
Slightly volatile
Long Term Debt To Capitalization0.30.320.6696
Slightly volatile
Total Debt To Capitalization0.02290.02410.6351
Slightly volatile
Quick Ratio4.973.26738.2831
Slightly volatile
Net Income Per E B T1.210.75861.0733
Very volatile
Cash Ratio4.152.58747.6858
Slightly volatile
Days Of Inventory Outstanding15.9216.7539167
Slightly volatile
Days Of Sales Outstanding40.2842.4033179
Slightly volatile
Fixed Asset Turnover460569247
Slightly volatile
Debt Ratio0.01540.01632.1907
Slightly volatile
Price Sales Ratio2.62.7387248
Slightly volatile
Asset Turnover0.430.71530.2596
Slightly volatile
Gross Profit Margin0.630.78060.7516
Pretty Stable

Harmony Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.8 B2 B2 B
Slightly volatile
Enterprise Value2.4 B1.5 B2.1 B
Pretty Stable

Harmony Fundamental Market Drivers

Forward Price Earnings9.6618
Cash And Short Term Investments467.2 M

Harmony Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Harmony Biosciences Financial Statements

Harmony Biosciences investors use historical fundamental indicators, such as Harmony Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Harmony Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue141.7 M95 M
Total Revenue714.7 M750.5 M
Cost Of Revenue156.8 M164.7 M
Stock Based Compensation To Revenue 0.06  0.06 
Sales General And Administrative To Revenue 0.15  0.15 
Research And Ddevelopement To Revenue 0.20  0.19 
Revenue Per Share 12.56  13.19 
Ebit Per Revenue 0.27  0.28 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for Harmony Stock Analysis

When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY